What laboratory tests should be monitored for a patient on atypical antipsychotics?

Monitoring fasting blood glucose, fasting lipid profile, and weight is crucial for patients on atypical antipsychotics because these medications are associated with metabolic side effects. Atypical antipsychotics can lead to weight gain, hyperglycemia, and dyslipidemia, which can increase the risk of diabetes and cardiovascular disease.

Fasting blood glucose levels help in detecting any changes in glucose metabolism, which can indicate the development of insulin resistance or diabetes. The fasting lipid profile evaluates cholesterol levels and triglycerides, allowing for the early identification of dyslipidemia. Weight monitoring is essential since substantial weight gain can be a direct consequence of these medications and can further complicate the patient's health status.

This comprehensive approach ensures that any metabolic disturbances are caught early, allowing for timely interventions to mitigate long-term health risks associated with atypical antipsychotic use.